Novel Dual Targeting T Cell Engager With Selective Tumor Activity in Solid Tumors
Time: 10:00 am
day: Conference Day 1
Details:
- Engineering strategy to increase the therapeutic index of T cell engager molecules
- Improving tumor selectivity to avoid on-target off-tumor toxicity
